Search PubMed⌕ Search

Biomedical subjects

A Eberhard

Publications and source records attributed to A Eberhard.

At least 55 records · Page 3Linked to original sources
PubMed1975

Studies on the mechanism of hyaluronate lyase action.

Hyaluronate lyase from streptococci group A was purified by chromatography on DEAE-Sephadex A-50 and on Biogel P-150, thereby enriching it about 1,000-fold and separating it into two enzyme fractions with the same amino acid composition. The photooxidation of hyaluronate lyase in the presence of methylene blue results in rapid inactivation of the enzyme. The histidine content of the enzyme is decreased considerably, but also the content of methionine, tyrosine, and lysine is lowered. The enzyme is inhibited, but incompletely so, by N-tosyl-L-phenyl-alanine-chloromethyl ketone (TPCK) and N-alpha-p-tosyl-L-lysine chloromethyl ketone (TLCK). Hyaluronic acid methyl ester, prepared form hyaluronic acid and diazomethane, is not split by hyaluronate lyase (EC 4.2.2.1.). Hyaluronic acid methyl ester is not a competitive inhibitor of hyaluronate lyase. For the mechanism of the enzymatic elimination reaction a proton transfer between histidine of the enzyme and the carboxylate group of hyaluronate is proposed.

Amino Acids↗
PubMed1972

Catabolite repression of bacterial bioluminescence: functional implications.

The synthesis of the bioluminescent system of the marine luminous bacterium Photobacterium fischeri (strain MAV) is subject to both transient and catabolite repression by glucose, and this repression can be reversed by adenosine 3':5'-cyclic monophosphate. Catabolite repression is a mechanism that characteristically controls the synthesis of inducible enzymes involved in energy metabolism. The fact that luciferase synthesis is subject to this control suggests that whatever its role(s) may be, it cannot be considered a nonfunctional or vestigial enzyme system as previously hypothesized, and may actually have some more direct role in metabolic processes.

Cyclic AMP↗
PubMed1972

Inhibition and activation of bacterial luciferase synthesis.

Luciferase synthesis is repressed when bioluminescent bacteria are inoculated into fresh medium but is induced after the cells have grown in the medium for some time. In minimal medium, an activator which leads to induction of the enzyme is released into the medium by the bacteria. Complete medium contains a dialyzable and quite stable inhibitor which leads to repression of luciferase. The bacteria remove the inhibitor from the medium and also produce activator, thus allowing synthesis of the enzyme. Two unidentified nonluminescent strains of bacteria were unable to remove the inhibitor. Two different bioluminescent strains, Photobacterium fischeri and P. fischeri strain MAV, produce specific activators that are ineffective with cells of the other strain. The two activators are different with respect to heat stability, but both are small molecules. The activators can be assayed on the basis of their ability to counteract the inhibitor. Identification of the inhibitor and the activators may allow the bioluminescent system to be linked to other metabolic processes of the cells.

Biochemical Phenomena↗